Company Search:
Advanced Search
Sponsored Links
Immunodiagnostic System HDQ Company Snapshot
Immunodiagnostic System HDQ operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Immunodiagnostic System HDQ with three other pharmaceutical manufacturers in Europe: Allergy Therapeutics PLC (2018 sales of £68.35 million [US$90.17 million] ), Summit Therapeutics PLC (£25.42 million [US$33.53 million] of which 100% was Drug Discovery), and Eco Animal Health Group Plc (£67.20 million [US$88.66 million] of which 100% was Animal Health Product).

Sales Analysis. During the year ended March of 2018, sales at Immunodiagnostic System HDQ were £37.95 million (US$50.06 million). This is a decrease of 5.2% versus 2017, when the company's sales were £40.04 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Immunodiagnostic System HDQ
  Stock Performance Chart for Immunodiagnostic System HDQ
  Stock Data: Recent Stock Performance:
  Current Price (10/12/2018): 216.00p
(Figures in Pounds Sterling)
1 Week 0.5%   13 Weeks -6.1%  
4 Weeks -15.6%   52 Weeks -34.5%  
Immunodiagnostic System HDQ Key Data:
  Ticker: IDH Country: United Kingdom
  Exchanges: LON Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2018 Sales 37,947,000
(Year Ending Jan 2019).
Employees: 283
  Currency: Pounds Sterling Market Cap: 63,473,678
  Fiscal Yr Ends: March Shares Outstanding: 29,385,962
  Share Type: Ordinary Closely Held Shares: 8,925,248
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.